Ontrak, Inc. (OTRKP) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Ontrak, Inc. (OTRKP) stock?
Ontrak, Inc. (OTRKP) no longer trades on public markets. The figures below are historical and are not a current quote.
Beta 1.53: the stock has moved about 53% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ontrak, Inc. (OTRKP). Ontrak, Inc. is a healthcare technology company focused on providing AI-powered, telehealth-enabled programs for chronic disease management. Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for OTRKP: OTRKP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OTRKP against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 24 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
OTRKP: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Ontrak, Inc. (OTRKP) Healthcare & Pipeline Overview
Ontrak, Inc. delivers AI-driven, telehealth-enabled healthcare solutions targeting chronic disease management through behavior change. The company's OnTrak program integrates psychosocial and medical interventions, addressing behavioral conditions linked to chronic illnesses, positioning it within the evolving healthcare information services sector.
What Is the Investment Thesis for OTRKP?
Ontrak, Inc. presents an investment case centered on its AI-driven approach to chronic disease management and telehealth capabilities. The company's OnTrak program targets a significant market need by addressing the behavioral components of chronic illnesses. However, potential investors may want to evaluate the company's negative profit margin of -228.1% and its presence on the OTC market, which introduces liquidity and regulatory risks. Growth catalysts include potential expansion of its OnTrak program to new health plans and geographic regions. The company's success hinges on demonstrating improved patient outcomes and cost savings to attract and retain clients. The high beta of 1.53 suggests higher volatility compared to the overall market.
Based on FMP financials and quantitative analysis
OTRKP Key Highlights
Ontrak operates with a negative Profit Margin of -228.1%, indicating significant losses relative to revenue.
- The company's Gross Margin stands at 55.1%, reflecting the profitability of its core services before operating expenses.
- Ontrak has a Beta of 1.53, suggesting its stock price is more volatile than the overall market.
- The company does not currently offer a dividend, reflecting a focus on reinvesting earnings for growth.
- Ontrak's market capitalization is $0.00B, indicating a small-cap company with potential for growth but also higher risk.
Who Are OTRKP's Competitors?
OTRKP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $262.25 | +0.49% | $42.6B | 905-pillar |
| GEHC GE HealthCare Technologies Inc. | $64.24 | -1.43% | $29.0B | 595-pillar |
| BTSG BrightSpring Health Services, Inc. | $57.88 | -6.63% | $11.4B | 695-pillar |
| TEM Tempus AI, Inc. | $59.29 | +0.93% | $10.4B | 315-pillar |
| TXG 10x Genomics, Inc. | $68.59 | +3.33% | $8.71B | 395-pillar |
| HQY HealthEquity, Inc. | $95.70 | +1.22% | $8.00B | 905-pillar |
| MTHRY M3, Inc. | $5.40 | +2.86% | $7.20B | 519-signal |
| HNGE Hinge Health, Inc. | $90.02 | +1.99% | $6.97B | 905-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are OTRKP's Key Strengths?
AI-powered platform for predicting and managing chronic disease.
- Integrated approach combining psychosocial and medical interventions.
- Telehealth-enabled delivery model for increased accessibility.
- Focus on addressing behavioral conditions that exacerbate chronic illnesses.
What Are OTRKP's Weaknesses?
Negative profit margin indicating financial instability.
- Reliance on a limited number of health plan clients.
- Limited market capitalization and liquidity.
- Presence on the OTC market, increasing regulatory and compliance risks.
What Could Drive OTRKP Stock Higher?
Expansion of the OnTrak program to new health plans and geographic regions.
- Development of new program modules to address additional chronic conditions.
- Integration with wearable devices and remote monitoring technologies.
- Leveraging AI and machine learning for personalized care.
- Potential positive results from studies demonstrating the effectiveness of the OnTrak program.
What Are the Key Risks for OTRKP?
Financial-distress signal — its Altman Z-Score of -45.16 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin and financial instability.
- Competition from other healthcare technology companies.
- Changes in healthcare regulations and reimbursement policies.
- Data breaches and privacy violations.
- Presence on the OTC market, increasing regulatory and compliance risks.
What Are the Growth Opportunities for OTRKP?
- Expansion into New Geographic Markets: Ontrak has the opportunity to expand its OnTrak program into new geographic markets within the United States. The market for chronic disease management is substantial, with significant unmet needs in underserved areas. By targeting specific regions with high prevalence of chronic conditions and limited access to care, Ontrak can increase its market reach and revenue. This expansion could involve partnerships with local healthcare providers and community organizations to build trust and ensure culturally competent care delivery. The timeline for this expansion is ongoing, with potential for accelerated growth in the next 3-5 years.
- Partnerships with Additional Health Plans: Ontrak can pursue partnerships with additional health plans to offer its OnTrak program to a wider member base. The market for health plan partnerships is competitive, but Ontrak's AI-driven platform and focus on behavioral health provide a unique value proposition. By demonstrating improved patient outcomes and cost savings, Ontrak can attract new health plan clients and expand its market share. The timeline for securing new health plan partnerships is ongoing, with potential for significant growth in the next 2-3 years.
- Development of New Program Modules: Ontrak can develop new program modules to address additional chronic conditions and behavioral health needs. The market for specialized chronic disease management programs is growing, with increasing demand for solutions that address specific patient populations and comorbidities. By expanding its program offerings, Ontrak can attract new clients and increase its revenue per member. This development could involve research and development efforts to identify unmet needs and develop evidence-based interventions. The timeline for developing new program modules is ongoing, with potential for new offerings in the next 1-2 years.
- Integration with Wearable Devices and Remote Monitoring Technologies: Ontrak can integrate its platform with wearable devices and remote monitoring technologies to enhance patient engagement and data collection. The market for wearable devices and remote monitoring is rapidly expanding, with increasing adoption among patients and healthcare providers. By integrating these technologies into its OnTrak program, Ontrak can provide more personalized and proactive care, improve patient adherence, and collect valuable data for program optimization. The timeline for integrating wearable devices and remote monitoring is ongoing, with potential for significant advancements in the next 1-3 years.
- Leveraging AI and Machine Learning for Personalized Care: Ontrak can further leverage its AI and machine learning capabilities to personalize care pathways and interventions for individual patients. The market for personalized medicine is growing, with increasing recognition of the importance of tailoring treatment to individual patient characteristics and preferences. By using AI to analyze patient data and predict individual responses to treatment, Ontrak can optimize its OnTrak program and improve patient outcomes. The timeline for leveraging AI for personalized care is ongoing, with potential for continuous improvement and innovation in the next 1-5 years.
What Are OTRKP's Competitive Advantages?
- Proprietary AI-powered platform for predicting and managing chronic disease.
- Integrated approach combining psychosocial and medical interventions.
- Telehealth-enabled delivery model for increased accessibility and convenience.
What Does OTRKP Do?
Ontrak, Inc., formerly Catasys, Inc., was founded in 2003 and rebranded in July 2020 to reflect its focus on AI-powered healthcare solutions. Headquartered in Henderson, Nevada, the company operates as a virtualized healthcare provider, offering in-person and telehealth services to health plans and third-party payors across the United States. Ontrak's core offering is its technology-enabled OnTrak program, designed to predict individuals whose chronic diseases can be improved through behavioral changes. The platform recommends personalized care pathways and guides patients through necessary interventions. The OnTrak program specifically targets members with behavioral conditions that worsen chronic medical conditions such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The program integrates evidence-based psychosocial and medical interventions, delivered via telehealth or in-person, along with care coaching and community care coordinators who address social and environmental determinants of health. Ontrak aims to improve patient outcomes and reduce healthcare costs by addressing the behavioral aspects of chronic disease management.
What Products and Services Does OTRKP Offer?
- Provides an AI-powered, telehealth-enabled healthcare platform.
- Offers virtualized healthcare services to health plans and third-party payors.
- Predicts individuals whose chronic disease will improve with behavior change.
- Recommends effective care pathways tailored to individual needs.
- Engages and guides patients through the care they need.
- Delivers the OnTrak program for members with behavioral conditions that exacerbate chronic medical conditions.
- Integrates psychosocial and medical interventions via telehealth or in-person.
- Offers care coaching and community care coordination to address social determinants of health.
How Does OTRKP Make Money?
- Generates revenue by providing its OnTrak program to health plans and other third-party payors.
- Charges fees based on member enrollment and engagement in the OnTrak program.
- Aims to reduce healthcare costs for payors by improving patient outcomes and reducing hospitalizations.
What Industry Does OTRKP Operate In?
Ontrak, Inc. operates within the healthcare information services industry, a sector experiencing rapid growth due to the increasing adoption of telehealth and AI-driven solutions. The industry is characterized by a competitive landscape with companies offering various approaches to chronic disease management and patient engagement. Market trends include a shift towards value-based care, personalized medicine, and remote patient monitoring. Ontrak's focus on integrating behavioral health with chronic disease management positions it within a niche segment of the broader healthcare IT market. Competitors such as ALEAF, GWPC, HHPHF, HRTT, and HTPRF also operate in the broader healthcare and telehealth space.
Who Are OTRKP's Key Customers?
- Health plans seeking to improve outcomes for members with chronic conditions.
- Third-party payors looking to reduce healthcare costs.
- Individuals with behavioral conditions that exacerbate chronic medical conditions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● Latest filing 479 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 48 |
| 2026-08-24 | 48 |
| 2026-08-25 | 48 |
| 2026-08-26 | 48 |
What changed?
The score has stayed at 48.
Over the same 3 days the stock moved +0.0%.
Insider Activity
The most recent 12 insider filings for Ontrak, Inc. break down as 3 sales and 9 purchases. On net that is roughly 4.6M shares acquired (about $7.1M) — insiders putting money in tends to read as conviction.
Forward Outlook
Wall Street analysts project Ontrak, Inc. revenue of about $24.8M for fiscal 2026, with EPS near $0.00.
Financial Health
Ontrak, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -45.16 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -66.0%, showing how much profit it generates from its asset base. A current ratio of 0.72 means current liabilities exceed short-term assets, a liquidity point worth watching.
OTRKP Revenue & Earnings Trend
In Q1 FY2025, OTRKP generated $2.0M in top-line revenue, marking a sequential decrease of 35.9%. The company recorded a net loss of $6.9M, with diluted EPS of $-1.25. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Healthcare. Across the four most recent quarters, OTRKP averaged $-1.42 in diluted EPS.
Company Profile
Ontrak, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Henderson, US. The company is led by CEO Brandon H. LaVerne CPA. OTRKP has traded publicly since 2020.
OTRKP Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- AI-powered platform for predicting and managing chronic disease.
- Integrated approach combining psychosocial and medical interventions.
- Telehealth-enabled delivery model for increased accessibility.
- Focus on addressing behavioral conditions that exacerbate chronic illnesses.
Bear Case
- Negative profit margin indicating financial instability.
- Reliance on a limited number of health plan clients.
- Limited market capitalization and liquidity.
- Presence on the OTC market, increasing regulatory and compliance risks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2025 | $2M | -$7M | -$1.25 |
| Q4 FY2024 | $3M | -$5M | -$0.95 |
| Q3 FY2024 | $3M | -$6M | -$1.26 |
| Q2 FY2024 | $2M | -$10M | -$2.21 |
Q1 FY2025 · filed 20 May 2025 · SEC EDGAR →
Based on FMP financials and quantitative analysis
OTRKP Latest News
-
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga · Oct 19, 2023
-
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga · Mar 2, 2023
-
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga · Feb 14, 2023
-
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga · Jan 18, 2023
Latest News
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
Leadership: Brandon H. LaVerne CPA
CEO
Brandon H. LaVerne is a Certified Public Accountant (CPA) and serves as the Chief Executive Officer of Ontrak, Inc. His background includes experience in financial management and accounting. As CEO, he is responsible for overseeing the company's strategic direction, financial performance, and overall operations. His CPA designation suggests a strong understanding of financial reporting and regulatory compliance.
Track Record: Since becoming CEO, Brandon H. LaVerne has been focused on navigating the challenges and opportunities in the healthcare technology sector. Specific achievements and strategic decisions under his leadership are not detailed in the provided data. However, his role involves guiding the company's efforts to expand its OnTrak program and secure new health plan partnerships.
OTRKP OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Ontrak, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, minimal assets, or are undergoing financial distress. Trading on the OTC Other tier carries significantly higher risks compared to exchanges like the NYSE or NASDAQ due to less stringent listing standards and regulatory oversight. Investors should be aware that information availability and transparency may be limited.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Higher risk of fraud and manipulation.
- Potential for delisting and loss of investment.
- Significant price volatility due to low trading volume.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's cash flow and financial stability.
- Review the company's legal and regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Established operating history since 2003.
- Focus on a growing market segment (chronic disease management).
- AI-powered platform with potential for innovation.
- Partnerships with health plans (details not provided).
Common Questions About OTRKP (Healthcare)
What happened to Ontrak, Inc. (OTRKP) stock?
Ontrak, Inc. (OTRKP) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy OTRKP shares?
No. OTRKP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for OTRKP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OTRKP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ontrak, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Ontrak, Inc. do?
Ontrak, Inc. operates as a healthcare technology company providing AI-powered, telehealth-enabled programs for chronic disease management. Their core offering is the OnTrak program, which integrates psychosocial and medical interventions to improve outcomes for individuals with behavioral conditions that exacerbate chronic illnesses such as diabetes, hypertension, and heart disease.
What do analysts say about OTRKP stock?
Due to the limited information and the company's OTC listing, analyst coverage and consensus are not readily available. Potential investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.
What are the main risks for OTRKP?
The main risks for Ontrak, Inc. include its negative profit margin and financial instability, which raise concerns about its long-term viability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for comprehensive analysis.
- OTC market listing increases investment risk.